Camurus Ab Stock Analysis
| CAMRF Stock | USD 71.00 0.00 0.00% |
Camurus AB holds a debt-to-equity ratio of 0.025. Camurus AB's financial risk is the risk to Camurus AB stockholders that is caused by an increase in debt.
Given that Camurus AB's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Camurus AB is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Camurus AB to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Camurus AB is said to be less leveraged. If creditors hold a majority of Camurus AB's assets, the OTC Stock is said to be highly leveraged.
Camurus AB is undervalued with Real Value of 81.78 and Hype Value of 71.0. The main objective of Camurus AB otc analysis is to determine its intrinsic value, which is an estimate of what Camurus AB is worth, separate from its market price. There are two main types of Camurus AB's stock analysis: fundamental analysis and technical analysis.
The Camurus AB otc stock is traded in the USA on OTCGREY Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Camurus AB's ongoing operational relationships across important fundamental and technical indicators.
Camurus |
Camurus OTC Stock Analysis Notes
About 53.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.63. Camurus AB had not issued any dividends in recent years. Camurus AB , a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. Camurus AB was founded in 1991 and is headquartered in Lund, Sweden. Camurus Ab is traded on OTC Exchange in the United States.The quote for Camurus AB is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Camurus AB please contact the company at 46 4 62 86 57 30 or go to https://www.camurus.com.Camurus AB Investment Alerts
| The company reported the revenue of 4.5 M. Net Loss for the year was (23.45 M) with profit before overhead, payroll, taxes, and interest of 515.22 M. | |
| Camurus AB has accumulated about 22.42 M in cash with (24.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Roughly 53.0% of the company shares are held by company insiders |
Camurus Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 853.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Camurus AB's market, we take the total number of its shares issued and multiply it by Camurus AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Camurus Profitablity
Camurus AB's profitability indicators refer to fundamental financial ratios that showcase Camurus AB's ability to generate income relative to its revenue or operating costs. If, let's say, Camurus AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Camurus AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Camurus AB's profitability requires more research than a typical breakdown of Camurus AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.62) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Technical Drivers
As of the 11th of February 2026, Camurus AB shows the Risk Adjusted Performance of 0.1274, standard deviation of 2.29, and Mean Deviation of 0.8532. Camurus AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for eleven technical drivers for Camurus AB, which can be compared to its peers. Please confirm Camurus AB standard deviation and maximum drawdown to decide if Camurus AB is priced correctly, providing market reflects its regular price of 71.0 per share. Given that Camurus AB has variance of 5.23, we suggest you to validate Camurus AB's prevailing market performance to make sure the company can sustain itself at a future point.Camurus AB Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Camurus AB price series with the more recent values given greater weights.
Camurus AB Predictive Daily Indicators
Camurus AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Camurus AB otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Camurus AB Forecast Models
Camurus AB's time-series forecasting models are one of many Camurus AB's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Camurus AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Camurus AB Debt to Cash Allocation
Many companies such as Camurus AB, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has a current ratio of 3.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Camurus AB until it has trouble settling it off, either with new capital or with free cash flow. So, Camurus AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Camurus AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Camurus to invest in growth at high rates of return. When we think about Camurus AB's use of debt, we should always consider it together with cash and equity.Camurus AB Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Camurus AB's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Camurus AB, which in turn will lower the firm's financial flexibility.About Camurus OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Camurus AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Camurus shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Camurus AB. By using and applying Camurus OTC Stock analysis, traders can create a robust methodology for identifying Camurus entry and exit points for their positions.
Camurus AB , a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. Camurus AB was founded in 1991 and is headquartered in Lund, Sweden. Camurus Ab is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Camurus AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Complementary Tools for Camurus OTC Stock analysis
When running Camurus AB's price analysis, check to measure Camurus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Camurus AB is operating at the current time. Most of Camurus AB's value examination focuses on studying past and present price action to predict the probability of Camurus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Camurus AB's price. Additionally, you may evaluate how the addition of Camurus AB to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |